Arnav Agarwal
Impact in
- Immunology and Allergy top 0.2%
- Allergic Rhinitis and Sensitization
- Internal Medicine top 0.5%
- Venous Thromboembolism Diagnosis and Management
Papers in
-
- Meta-analysis and systematic reviews 43
-
- Venous Thromboembolism Diagnosis and Management 18
- Co-authors
- Gordon Henry Guyatt (55 shared papers)Kari A.O. Tikkinen (18 shared papers)Holger Jens Schünemann (14 shared papers)Yuan Zhang (7 shared papers)Elie A. Akl (15 shared papers)John P. A. Ioannidis (8 shared papers)Juan José Yepes-Núñez (7 shared papers)Neera Bhatnagar (10 shared papers)
- Journals
- Journal of Clinical Epidemiology (24 papers)BMJ (19 papers)BMJ Open (16 papers)JAMA Network Open (9 papers)Blood Advances (8 papers)
- Partner nations
- CanadaUnited StatesSwitzerland
In The Last Decade
Arnav Agarwal
249 papers receiving 26k citations
Arnav Agarwal's Hit Papers
Peers
Comparison fields: 5 of 207
- Immunology and Allergy 1.7k
- Internal Medicine 653
- Infectious Diseases 2.1k
- Pharmacology 1.3k
- Statistics, Probability and Uncertainty 680
Countries citing papers authored by Arnav Agarwal
This map shows the geographic impact of Arnav Agarwal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Arnav Agarwal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Arnav Agarwal more than expected).
Fields of papers citing papers by Arnav Agarwal
This network shows the impact of papers produced by Arnav Agarwal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Arnav Agarwal. The network helps show where Arnav Agarwal may publish in the future.
Co-authors
The 25 scholars most cited alongside Arnav Agarwal, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 262 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015 Hit paper breakdown → | 2016 | 5916 |
| 2 | Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015: a systematic analysis for the Global Burden of Disease Study 2015 Hit paper breakdown → | 2016 | 5412 |
| 3 | Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines—2016 revision Hit paper breakdown → | 2017 | 1468 |
| 4 | Global, regional, and national levels of maternal mortality, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015 Hit paper breakdown → | 2016 | 877 |
| 5 | 2020 | 809 | |
| 6 | 2020 | 636 | |
| 7 | Opioids for Chronic Noncancer Pain Hit paper breakdown → | 2018 | 538 |
| 8 | Measuring the health-related Sustainable Development Goals in 188 countries: a baseline analysis from the Global Burden of Disease Study 2015 Hit paper breakdown → | 2016 | 466 |
| 9 | 2020 | 462 | |
| 10 | American Society of Hematology 2018 guidelines for management of venous thromboembolism: optimal management of anticoagulation therapy Hit paper breakdown → | 2018 | 390 |
| 11 | World Allergy Organization-McMaster University Guidelines for Allergic Disease Prevention (GLAD-P): Probiotics Hit paper breakdown → | 2015 | 377 |
| 12 | Surgical site infection after gastrointestinal surgery in high-income, middle-income, and low-income countries: a prospective, international, multicentre cohort study Hit paper breakdown → | 2018 | 352 |
| 13 | Probiotics for the prevention of allergy: A systematic review and meta-analysis of randomized controlled trials Hit paper breakdown → | 2015 | 310 |
| 14 | 2017 | 287 | |
| 15 | Global variation in postoperative mortality and complications after cancer surgery: a multicentre, prospective cohort study in 82 countries Hit paper breakdown → | 2021 | 240 |
| 16 | 2021 | 218 | |
| 17 | Benefits and harms of drug treatment for type 2 diabetes: systematic review and network meta-analysis of randomised controlled trials Hit paper breakdown → | 2023 | 212 |
| 18 | 2014 | 205 | |
| 19 | Meta-analysis of antibiotics versus appendicectomy for non-perforated acute appendicitis Hit paper breakdown → | 2016 | 202 |
| 20 | 2020 | 170 |
About Arnav Agarwal
Arnav Agarwal is a scholar working on Statistics, Probability and Uncertainty, Internal Medicine, Public Health, Environmental and Occupational Health, Statistics and Probability and Pharmacology, having authored 262 papers that have together received 27k indexed citations. Recurring topics across this work include Meta-analysis and systematic reviews (43 papers), Venous Thromboembolism Diagnosis and Management (18 papers), Statistical Methods in Clinical Trials (12 papers), COVID-19 Clinical Research Studies (12 papers), Pharmaceutical industry and healthcare (11 papers), Diabetes Treatment and Management (10 papers), Academic Publishing and Open Access (10 papers) and Clinical practice guidelines implementation (9 papers). The work is most often cited by research in Immunology and Allergy (1.7k citations), Internal Medicine (653 citations), Infectious Diseases (2.1k citations), Pharmacology (1.3k citations) and Statistics, Probability and Uncertainty (680 citations). Arnav Agarwal has collaborated with scholars based in Canada, United States and Switzerland. Frequent co-authors include Gordon Henry Guyatt, Kari A.O. Tikkinen, Holger Jens Schünemann, Yuan Zhang, Elie A. Akl, John P. A. Ioannidis, Juan José Yepes-Núñez, Neera Bhatnagar, Alessandro Giovanni Fiocchi and Carlos A. Cuello‐García. Their work appears in journals such as Journal of Clinical Epidemiology, BMJ, BMJ Open, JAMA Network Open and Blood Advances.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.